Refine by
Biotechnology Engineering Articles & Analysis
39 news found
This special offer is valid through December 4, 2024, at 23:59 EST.Our monodispersed PEGs are highly versatile and indispensable in various pharmaceutical and biotechnological applications. These precision-engineered compounds are widely used in PEGylation, a process that enhances the pharmacokinetics and stability of therapeutic molecules. ...
Recombinant indicates that this enzyme is produced using advanced biotechnological methods, specifically genetic engineering. This method ensures fidelity and reproducibility of the enzyme, which are essential for consistent research results and large-scale applications. ...
A HPR-20 R&D with an all-metal variable leak valve inlet system was recently installed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart. In a research project within the Group of Algae Biotechnology Development, hydrogen is produced using the microalgae C. reinhardtii. ...
Profacgen, one of the leading biotechnology companies that provides first-class protein expression services, recently announced the release of multi-protein expression service in insect cells, to help scientists conduct protein co-expression network analysis and interaction studies. ...
Achema is the world’s largest exhibition for chemical engineering, process technology and biotechnology. Modern, interactive and always up-to-date: with a unique range of topics, exciting central themes and new event formats, the world’s leading trade fair for the process industries brings together experts and decision-makers from all over the world. ...
Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs), and Peptilogics, a biotech company engineering peptide therapeutics by combining computation and biology to improve the treatment landscape for patients with life-threatening diseases, announced today that they have entered a research and ...
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced it will present enhancements to its proprietary cytoDRIVE® technology during a poster presentation at the 25th ASGCT Annual Meeting. ...
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced it will present preclinical data highlighting its cytoTIL15™ program during a poster session at the upcoming AACR Annual Meeting 2022. ...
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced it will present data highlighting the potential of the company’s cytoDRiVE® platform technology, which allows regulation of protein expression using small molecule drugs. ...
Researchers at Lumen Bioscience report in Nature Biotechnology their groundbreaking genetic engineering methods to highly express bioactive proteins in spirulina using large-scale cultivation and processing methods appropriate for biopharmaceutical manufacturing. ...
Laurencin is a distinguished university professor, award-winning engineer, orthopaedic surgeon, scientist, administrator, and pioneer in the field of regenerative engineering. ...
ByAlkermes
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced that the Company will present preclinical in vivo anti-tumor efficacy against melanoma data for its cytoTIL15™ program at the upcoming Annual Meeting of the Society for Immunotherapy of Cancer (SITC). ...
” About Evox Therapeutics Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. ...
Obsidian Therapeutics, a biotechnology company pioneering engineered cell and gene therapies, today announced that the Company will present data highlighting its cytoTIL15™ program at the upcoming European Society for Medical Oncology (ESMO) Congress, which will be hosted virtually September 16-21, 2021. ...
Obsidian Therapeutics, a biotechnology company pioneering engineered cell and gene therapies, today announced that the Company will present at the upcoming 24th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, which will be hosted virtually May 11-14, 2021. ...
About Obsidian Therapeutics Obsidian Therapeutics, Inc. is a biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. The Company expects to submit an IND in mid-2022 for its lead cytoTIL™ program, a novel engineered tumor infiltrating lymphocyte therapy ...
” NNI states that its 2021 NanoEHS webinar series will focus on sharing what it now knows about the environmental, health, and safety aspects of engineered nanomaterials (nanoEHS). According to NNI, throughout the series, “experts will share the big take-home EHS messages with the broader nanotechnology community and highlight the NNI’s role in answering those ...
Oded Nir of the Zuckerberg Institute for Water Research and Professor Ariel Kushmaro of the Avram and Stella Goldstein-Goren Department of Biotechnology Engineering have led the first survivability study on COVID-19 using RNA detection. ...
Cambrian Innovation’s EcoVolt® product suite applies cutting-edge biotechnology and engineering to convert wastewater into clean water and renewable energy for industrial manufacturers and independent communities. ...
Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year BlueRock Therapeutics to continue to operate as an independent company Bayer AG and BlueRock Therapeutics today announced an agreement ...